Cryptocurrencies
Lilly looks beyond obesity with $2.88B autoimmune buyout
Eli Lilly (LLY) has spent the last two years as the company everyone points to when they talk about weight-loss drugs. That reputation made it the most valuable pharmaceutical company in the world. It also Read more…